Advertisement
Advertisement

AQST

AQST logo

Aquestive Therapeutics, Inc. Common Stock

4.21
USD
Sponsored
-0.78
-15.59%
Jun 25, 12:39 UTC -4
Open

Aquestive Therapeutics, Inc. Common Stock Profile

About

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. It commercializes medicines to solve critical health care problems as well as engages on late-stage proprietary product pipeline which focuses on the treatment of diseases of central nervous system. Aquestive Therapeutics, Inc. is based in NJ, United States.

Info & Links

CEO

Daniel Barber

Headquarters

30 TECHNOLOGY DRIVE
WARREN, NJ 07059, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.aquestive.com

Auditor

KPMG LLP

Share holders

72

Employees

147

Aquestive Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

528.40M

Enterprise Value

442.76M

Enterprise Value/EBITDA(ttm)

-9.87

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

11.43

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

58.12%

Operating Margin(ttm)

-188.09%

Profit Margin(ttm)

-190.95%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

576.44%

Return on Assets(ttm)

-64.46%

Income Statement

Revenue(ttm)

50.27M

Revenue Per Share(ttm)

0.40

Gross Profit(ttm)

31.90M

EBITDA(ttm)3

-44.84M

Net Income Available to Common(ttm)

-68.91M

Diluted EPS(ttm)

-0.78

Share Statistics

Beta (5Y Monthly)

1.54

52-Week Change

31.21%

S&P 500 52-Week Change

21.03%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

125.45M

Dividend Yield

0.00%

Float4

111.85M

% Held by Insiders

8.35%

% Held by Institutions

32.45%

Balance Sheet

Total Cash(mrq)

110.73M

Total Cash Per Share(mrq)

0.88

Total Debt(mrq)

25.10M

Total Debt/Equity(mrq)

-81.75%

Current Ratio(mrq)

3.14%

Quick Ratio(mrq)

3.01%

Book Value Per Share(mrq)

-0.28

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.49

Free Cash Flow(ytd)

-52.99M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement